Biosimilars

Channel: Biosimilars

↧

Clinical efficacy and safety of Zarzio® (EP2006), a biosimilar...

:0

:0

March 11, 2014, 4:00 am

View Article

Production and analysis of a biosimilar erythropoietin in Egypt

:0

:0

May 9, 2014, 5:00 am

View Article

Multidisciplinary approach to evaluating immunogenicity of biosimilars:...

:0

:0

June 24, 2014, 5:00 am

View Article

Production and manufacturing of biosimilar insulins: implications for...

:0

:0

November 9, 2014, 3:15 pm

View Article

Physicochemical and functional characterization of a biosimilar adalimumab...

:0

:0

December 30, 2014, 3:04 pm

View Article

Global regulatory landscape of biosimilars: emerging and established market...

:0

:0

February 16, 2015, 1:08 pm

View Article

Challenging issues in assessing analytical similarity in biosimilar studies

:0

:0

May 21, 2015, 3:46 pm

View Article

Establishing a new marketplace for biologic therapy with biosimilar agents:...

:0

:0

May 31, 2015, 7:20 pm

View Article

Clinical trials in the development of biosimilars: future considerations

:0

:0

July 8, 2015, 10:31 pm

View Article

Clinical efficacy and safety of biosimilar epoetin: focus on epoetin zeta

:0

:0

September 8, 2015, 4:35 pm

View Article

Low immunogenicity but reduced bioavailability of an interferon beta-1a...

:0

:0

September 14, 2015, 4:40 pm

View Article

Label-free interaction analysis as a tool to demonstrate biosimilarity of...

:0

:0

September 15, 2015, 6:32 pm

View Article

Pharmacokinetic and pharmacodynamic properties of a new biosimilar filgrastim...

:0

:0

November 2, 2015, 4:56 pm

View Article

Development, safety, and efficacy of biosimilar adalimumab: the data so far

:0

:0

January 28, 2016, 4:56 pm

View Article

Considerations in biosimilar insulin device development

:0

:0

February 15, 2016, 5:49 pm

View Article

Tools for the analysis and characterization of therapeutic protein species

:0

:0

May 4, 2016, 8:02 pm

View Article

"Step" versus "phase" in the clinical development of...

:0

:0

June 21, 2016, 4:37 pm

View Article

Adalimumab: a review of the reference product and biosimilars

:0

:0

July 25, 2016, 6:16 pm

View Article

Physicochemical and biological comparison of the first Brazilian biosimilar...

:0

:0

August 29, 2016, 5:06 pm

View Article

Scientific factors for assessing biosimilarity and drug interchangeability of...

:0

:0

June 15, 2011, 5:00 am

View Article

Critical appraisal of biosimilar filgrastim (Nivestim™) for febrile and...

:0

:0

August 19, 2012, 5:00 am

View Article

Clinical efficacy and safety of HX575, a biosimilar recombinant human...

:0

:0

September 5, 2012, 5:00 am

View Article

The development and introduction of biosimilar anticoagulants – focus...

:0

:0

September 12, 2012, 5:00 am

View Article

A European perspective on the market accessibility of biosimilars

:0

:0

November 15, 2012, 3:00 am

View Article

Similar biotherapeutic products in Latin America. Regulation and...

:0

:0

January 3, 2013, 3:00 am

View Article

Rituximab and biosimilars – equivalence and reciprocity

:0

:0

June 13, 2013, 5:00 am

View Article

Current and future biosimilars: potential practical applications in rheumatology

:0

:0

July 31, 2013, 5:00 am

View Article

Clinical efficacy and safety of SB309, a biosimilar recombinant human...

:0

:0

August 20, 2013, 5:00 am

View Article

Clinical efficacy and safety of XM01, a biosimilar recombinant human...

:0

:0

August 26, 2013, 5:00 am

View Article

Clinical efficacy and safety of Tevagrastim® (XM02), a biosimilar...

:0

:0

August 26, 2013, 5:00 am

View Article

© 2025 //www.rssing.com